Caladrius
Caladrius is a New Jersey-based biopharmaceutical company that develops and commercializes cell therapies for the regeneration of damaged tissues.
Business Model:
Revenue: $16M
Employees: 11-50
Industries / Tags:
Detailed Caladrius Information
Geographic Data
Address: 110 Allen Road
City: Basking Ridge
State: NJ
Zip: 07920
Country: US
Financial Info
Stage:
grant
Raised Last:
$1M
Raised Total:$166M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Caladrius is a New Jersey-based biopharmaceutical company that develops and commercializes cell therapies for the regeneration of damaged tissues.
Contact Phone:
+19088420100
Contact Email:
Caladrius went public on 1/14/2000 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
1/14/2000
Ticker Symbol:
CLBS
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2020 | Post-IPO Equity | $2M | 2/2022 | Post-IPO Equity | $2.3M | 10/2017 | Grant | 1 | $1.9M |
National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health |
11/2012 | Grant | 1 | $1.2M |
National Institutes of Health National Institutes of Health |
5/2021 | Grant | $0 |
New Jersey Economic Development Authority New Jersey Economic Development Authority |
1/2021 | Post-IPO Equity | $25M | 4/2009 | Post-IPO Equity | $0 |
RimAsia Capital Partners RimAsia Capital Partners |
9/2016 | Post-IPO Equity | $12.6M | 5/2020 | Post-IPO Equity | $4.3M | 5/2014 | Post-IPO Equity | $38M | 9/2013 | Grant | 1 | $147.8k |
National Institutes of Health National Institutes of Health |
2/2021 | Post-IPO Equity | $65M | 4/2020 | Post-IPO Equity | $5M | 5/2021 | Grant | 1 | $1.4M |
New Jersey Economic Development Authority New Jersey Economic Development Authority |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 4/2022 | Cend Therapeutics Inc. | |
| 4/2014 | California Stem Cell | |
| 7/2011 | Amorcyte | |
| 1/2011 | PCT Cell Therapy Services | |
| 1/2011 | Progenitor Cell Therapy |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
